Organizer
SCIEX
SCIEX
SCIEX helps to improve the world we live in by enabling scientists and laboratory analysts to find answers to the complex analytical challenges they face. The company's global leadership and world-class service and support in the capillary electrophoresis and liquid chromatography-mass spectrometry industry have made it a trusted partner to thousands of the scientists and lab analysts worldwide who are focused on basic research, drug discovery and development, food and environmental testing, forensics and clinical research.
Tags
OMICS
LC/MS
LinkedIn Logo

Precision lipidomics: Targeted assays for genetic disorder monitoring

RECORD | Already taken place Th, 13.6.2024
This webinar will explore the development of two distinct lipid assays that are underway to provide a more efficient and comprehensive approach to improve screening of various genetic disorders.
Go to the webinar
SCIEX: Precision lipidomics: Targeted assays for genetic disorder monitoring
SCIEX: Precision lipidomics: Targeted assays for genetic disorder monitoring

Unlock the secrets of personalized healthcare and a new era of precision medicine in omics

Welcome to our Precision medicine unleashed multi-part webinar series that delves into the fascinating world of mass spectrometry applications in lipidomics, proteomics and metabolomics.

In this series, we will explore the power of the revolutionary technology around mass spectrometry and its immense potential to transform the field of precision medicine. From unraveling intricate lipid profiles to deciphering the complexities of proteomic landscapes and metabolite networks, we’ll uncover remarkable advancements and breakthroughs in these fields. Be sure to check back for more webinars we have coming up!

Precision lipidomics: Targeted assays for genetic disorder monitoring

The dysregulation of lipids plays a role in the development and progression of various genetic disorders such as Tay-Sachs, Sandhoff disease and Barth syndrome. The cause of these disorders is often a result of the deficiency of enzymes involved in lipid metabolism. This webinar will explore the development of two distinct lipid assays that are underway to provide a more efficient and comprehensive approach to improve screening of various genetic disorders.

Presenter: Seul Kee Byeon (Assistant Professor, Mayo Clinic)

SCIEX
LinkedIn Logo
 

Related content

Comprehensive and Robust Analysis of Ultrashort- to Long-Chain PFAS, PAE, OPE, and PAH

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS
Manufacturer
Agilent Technologies, Plasmion
Industries
Environmental

UPLC™ Separation of Fifteen Bisphenols Using a Waters Acquity™ Biphenyl RP Column with MaxPeak™ Premier Technology and UV Detection

Applications
| 2026 | Waters
Instrumentation
Consumables, LC columns, HPLC
Manufacturer
Waters
Industries
Pharma & Biopharma

Achieving Low‑ppb Bisphenol Quantitation with the Agilent InfinityLab Pro iQ Mass Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/SQ
Manufacturer
Agilent Technologies
Industries
Materials Testing

ECL detection of fentanyl

Applications
| 2026 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Forensics

Early-stage drug metabolite quantitation without radiolabels

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
HPLC, LC/MS, LC/SQ
Manufacturer
Thermo Fisher Scientific
Industries
Pharma & Biopharma, Metabolomics
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike